Macquarie Group’s NRC Health Common Stock NRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-170
Closed -$6.29K 2410
2022
Q2
$7K Hold
170
﹤0.01% 2489
2022
Q1
$7 Hold
170
﹤0.01% 2555
2021
Q4
$7K Hold
170
﹤0.01% 2550
2021
Q3
$7K Hold
170
﹤0.01% 2578
2021
Q2
$8K Hold
170
﹤0.01% 2493
2021
Q1
$8K Sell
170
-80
-32% -$3.89K ﹤0.01% 2414
2020
Q4
$11K Hold
250
﹤0.01% 2297
2020
Q3
$12K Hold
250
﹤0.01% 2260
2020
Q2
$15K Buy
+250
New +$13.2K ﹤0.01% 2234
2018
Q1
Sell
-8,840
Closed -$330K 2307
2017
Q4
$330K Sell
8,840
-4,102
-32% -$146K ﹤0.01% 1573
2017
Q3
$488K Buy
+12,942
New +$407K ﹤0.01% 1453

Other funds holding NRC

Macquarie Group's NRC Position: Q3 2022 in Review

Macquarie Group sold out of NRC Health Common Stock (NRC) in Q3 2022, closing a stake of 170 shares — an estimated $6.29K sold.

Macquarie Group first reported a position in NRC in Q3 2017 and held it in 11 quarters. The position peaked at $488K in Q3 2017. 110 funds tracked by Wall St. Rank hold NRC as of Q3 2022.

  • Macquarie Group reported no remaining NRC Health Common Stock position as of Q3 2022 after selling out during the quarter.
  • Macquarie Group sold 170 NRC Health Common Stock shares in Q3 2022, an estimated $6.29K.
  • Macquarie Group first reported a position in NRC Health Common Stock in Q3 2017 and held it in 11 quarters.
  • Macquarie Group's NRC Health Common Stock position peaked at $488K in Q3 2017.
  • 110 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q3 2022.

Based on Macquarie Group's 13F filing for Q3 2022, filed 14 Nov 2022.